Sickle cell anemia treatment safely lowers disease burden in African children

IMAGE: Russell Ware M.D., director of Hematology at the Cincinnati Children’s Hospital Medical Center, was senior investigator on a multi-national clinical trial focused on improving health outcomes for children in sub-Saharan…
view more 

Credit: Cincinnati Children’s

CINCINNATI – A daily hydroxyurea pill may finally bring some relief for young children living with the painful and deadly blood disease sickle cell anemia (SCA) in resource-challenged sub-Saharan Africa, where the disease is prevalent and health care availability is suboptimal.

This is what a large multinational clinical trial called REACH discovered when it tested daily hydroxyurea treatment in 606 children between the ages of 1 and 10 years old. The children took a pill each day for six months,…

Read More